# Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment

> **NCT01144286** · PHASE2 · COMPLETED · sponsor: **Ferrer Internacional S.A.** · enrollment: 229 (actual)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** arasertaconazole nitrate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01144286
- **Lead sponsor:** Ferrer Internacional S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2013-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144286, "Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01144286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*